These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 34117733)
1. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer. Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733 [TBL] [Abstract][Full Text] [Related]
2. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique. Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335 [TBL] [Abstract][Full Text] [Related]
3. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI. Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002 [TBL] [Abstract][Full Text] [Related]
4. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer. Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701 [TBL] [Abstract][Full Text] [Related]
5. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4. Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status. Lai B; Yi Y; Yang X; Li X; Xu L; Yan Z; Yang L; Han R; Hu H; Duan X Magn Reson Imaging; 2024 Oct; 112():136-143. PubMed ID: 39029603 [TBL] [Abstract][Full Text] [Related]
7. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status. Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974 [TBL] [Abstract][Full Text] [Related]
8. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness. Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414 [TBL] [Abstract][Full Text] [Related]
9. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer. Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737 [TBL] [Abstract][Full Text] [Related]
10. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors. He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327 [TBL] [Abstract][Full Text] [Related]
11. The Assessment of Prostate Cancer Aggressiveness Using a Combination of Quantitative Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Zhu G; Luo J; Ouyang Z; Cheng Z; Deng Y; Guan Y; Du G; Zhao F Cancer Manag Res; 2021; 13():5287-5295. PubMed ID: 34239327 [TBL] [Abstract][Full Text] [Related]
12. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135 [TBL] [Abstract][Full Text] [Related]
13. Relationship between histogram metrics of pharmacokinetic parameters of DCE-MRI and histological phenotype in breast cancer. Yang G; Yang J; Xu H; Zhang Q; Qi Y; Zhang A Transl Cancer Res; 2020 Jan; 9(1):30-41. PubMed ID: 35117155 [TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer. Du Y; Zhang S; Liang T; Shang J; Guo C; Lian J; Gong H; Yang J; Niu G Acta Radiol; 2023 Feb; 64(2):572-580. PubMed ID: 35369721 [TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease. Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655 [TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram. Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Feng YN; Wang MZ Acta Radiol; 2020 Sep; 61(9):1221-1227. PubMed ID: 31902220 [TBL] [Abstract][Full Text] [Related]
17. Histogram analysis of MR quantitative parameters: are they correlated with prognostic factors in prostate cancer? Chen Y; Meng T; Cao W; Zhang W; Ling J; Wen Z; Qian L; Guo Y; Lin J; Wang H Abdom Radiol (NY); 2024 May; 49(5):1534-1544. PubMed ID: 38546826 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study. Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837 [TBL] [Abstract][Full Text] [Related]
19. Whole solid tumor volume histogram parameters for predicting the recurrence in patients with epithelial ovarian carcinoma: a feasibility study on quantitative DCE-MRI. Li HM; Tang W; Feng F; Zhao SH; Gu WY; Zhang GF; Qiang JW Acta Radiol; 2020 Sep; 61(9):1266-1276. PubMed ID: 31955611 [TBL] [Abstract][Full Text] [Related]